Medical adhesives are a component of various products such as wound dressings, tapes for wound closure, and for securing devices, electrodes, ostomy supplies, and patches. These adhesives enable securing of both critical and noncritical devices and products, serve to protect skin and promote wound healing, permit noninvasive monitoring of wounds and sutures, etc.
Advancements in medical adhesives are resulting in increasing applications in biomedical and pharmaceutical sectors, and are currently used in various medical and surgical procedures, in the assembly of medical devices, securing components during intravenous drug delivery, urological surgical interventions, and plastic surgery procedures, among others.
With the advent of novel medical treatments and technologies, medical adhesives are increasingly being deployed in medical disposable device assemblies used in-home care settings. Medical adhesives are steadily replacing conventional catgut and nylon and absorbable and nonabsorbable surgical sutures and staples for closure of post-surgical incisions and wounds owing to low risk of adverse or side effects.
An increasing number of patients requiring treatment that necessitates the use of medical adhesives, the development of more robust and reliable medical-grade adhesives, and rapid innovations in medical adhesives are some key factors expected to continue to drive market revenue growth over the forecast period.
Medical adhesives are rapidly replacing traditional fastening systems in medical device assemblies and confer significant advantages over other mechanical fastening methods. Medical adhesives are available in various types such as structural, non-structural, pressure-sensitive, and sprays to cater to different attachment and assembly needs and applications. Structural adhesives are characterized by their excellent adhesion and load-bearing capabilities and are widely used in a range of medical device applications such as for bonding surgical instruments and equipment and in the attachment of rubber bumpers on the soles of crutches, canes, and walkers, among others.
Non-structural adhesives are used in non-critical assemblies and some common examples of non-structural adhesives include hot melts, aerosols, and rubber and gasket adhesives. Spray and hot melt adhesives are widely used for bonding foam to foam or fabric to metal such as in wheelchair seat cushions, which eliminates the need for stitching. Pressure-sensitive adhesives are extensively used in medical device assemblies due to their viscoelastic properties.
These adhesives are commonly used in the manufacturing of blood glucose monitoring strips and for attaching products and devices such as insulin pumps, surgical drapes, and wound dressing to the skin of patients. Increasing global demand for Personal Protective Equipment (PPE) following the COVID-19 pandemic has further contributed to the rising demand for medical adhesives that can be used in the production of face masks, shields, and medical drapes gowns.
Hot-melt adhesives and water-based adhesives are widely used in the production of high-quality medical protective wear that offers robust protection against exposure to infectious diseases, pathogens, and viruses.
The emergence of more infectious variants in countries across the globe and the rising need to reduce exposure, infection, and spread of viruses are further boosting demand for PPE kits, and in turn, contributing significantly to the revenue growth of the market.
To identify the key trends in the industry, a research study at https://www.reportsanddata.com/report-detail/medical-adhesives-market
While medical adhesives have little to no risk of side effects, there have been incidences of allergic contact dermatitis that is caused due to the presence of specific materials in some medical adhesives. In addition, certain high-quality medical adhesives are expensive and some may not be appropriate or compatible with all patients these factors can potentially restrain market growth to a certain extent over the forecast period. However, the development of bioadhesives with low potential to cause allergic reactions can expand applications of adhesives in the medical industry and open up robust revenue opportunities for major players in the market.
COVID-19 Impact Analysis
Social distancing and restrictions severely disrupted businesses and operations
Lockdowns caused disruptions in transportation and logistics
impacted manufacturing activities and mining operations globally
Took a toll on the economy of various countries
Caused sudden and drastic downturn in economic activity
Disrupted agriculture, fisheries, dairy, and other sectors
Caused loss of employment and financial crisis
Supply impacts were further compounded owing to reduced disposable income
The emergence of variants continues to cause concerns and impact normal routines
Synthetic and Semi-Synthetic Resin Segment to Account for Largest Revenue Share:
The synthetic and semi-synthetic resin segment is expected to account for the largest revenue share over the forecast period, attributable to the growing usage of synthetic and semi-synthetic resins in medical device assemblies and sealing, as excipients in transdermal patches, and as alternatives to conventional solvents in needle bonding, manufacturing of IV tube sets, and for attaching plastic tubes to blood bags.
Dental Segment to Register Steady Revenue Growth:
The dental segment is expected to register steady revenue growth over the forecast period owing to the increasing use of medical adhesives in the production of dentures, dental crowns, and caps, and in post-surgical wound dressing. In addition, increasing demand for braces and dental veneers owing to the rising popularity of cosmetic dental procedures to boost aesthetics and personal appearance, rising awareness regarding oral health, and availability of more cost-effective dental procedures are further expected to contribute to revenue growth of this segment going ahead.
North America to Account for a Significantly Large Revenue Share:
North America is expected to dominate other regions in terms of revenue share over the forecast period, attributable to the increasing use of advanced wound dressing and medical devices to enhance the safety and quality of life of patients, rising demand for durable medical devices due to rising need for patient monitoring devices amid growing caseload of COVID-19 infections, rapid advancements in manufacturing processes of medical adhesives, and presence of major players in countries in the region.
The Asia Pacific to Lead in Terms of Revenue Growth Rate:
Asia Pacific is expected to register robust revenue CAGR over the forecast period, attributable to high demand for PPE kits, increasing adoption of advanced medical devices high healthcare expenditure, advancements in healthcare infrastructure, rising need for more efficient wound closure materials due to the increasing number of surgeries performed, and increasing investment in R&D activities to develop newer lines of robust medical adhesives.
The reports include historical (2018–2020) and forecast (2021–2028) data points, revenues, and CAGR in the table, figure, and chart formats, with detailed and qualitative, supporting written information for each.
Revenue break-up is provided for each segment in these formats for global, regional, and for each country in the respective region for each year between 2018 and 2028.
The report contains insights regarding growth drivers, restraints, opportunities, trends, company profiles, strategic developments, expansion details, product launches, and various other aspects related to the market.
The report contains data and information on customers, competitors, vendors/distributors, and other players in the global marketplace.
The market research analysis is vital for all crucial business strategies and can aid in numerous ways and provide a clearer understanding of strategies being deployed by competitors, product launches, competitive analysis, technological advancements, and various other factors that enhance sales of a firm or perhaps provide insights to focus on merger and acquisition as a strategy or enter into strategic agreements or joint ventures, etc.
The report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, geographical reach, market footprint, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.
Explore Featured Blogs by Reports and Data:
2020’s Top 10 Leading HD Tablet Companies in the World
How Foldable Display Works: The Future of Smartphone Design
Smart Government Gains Traction As The Future of Public Services
Top 10 Most Powerful Supercomputers Leading The New Age Of Computing Excellence
Top 7 Trends That Will Shape The Textile Industry In 2021
2020’s Top 10 Leading Connected TV Device Companies in the World
Eyewear Industry: Driven by a Combinational Force of Eye Health Importance and Fashion Status
Increasing global demand for polypropylene post-COVID-19 outbreak
Role of Industrial Wastewater Treatment in Restoring Environmental Health
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problem provide our clients with the ability to secure an edge over their respective competitors.
These growth stocks aren’t household names. Yet.
Microstrategy CEO Michael Saylor started adding Bitcoin to his corporate treasury last year and hasn’t turned back. He said the only long-term risk to the crypto would be a “black swan.”
(Bloomberg) — The U.S. went on a borrowing binge last year and the hangover could make it harder for the Federal Reserve to fight inflation without crashing the economy. Most Read from BloombergZero Taxes, Golf and Beach Houses Create a Crypto Island ParadiseAnatomy of a Bad RoadBoris Johnson’s Furious MPs Worry That His Next Misstep Could Be FatalChina Is Building the World’s Largest National Park SystemThe 15 Best Beers We Drank This YearCorporate debt has surged $1.3 trillion since the start
If the level of expenses you provided is accurate, coupled with moderate inflation and an estimated investment growth rate of net 6% to 6.5%, your strategy should be able to hold you over until Social Security and then some, said Brian Robinson, a certified financial planner and partner at advisory firm SharePoint. “There are enough assets with different taxable circumstances that, if allocated correctly and in the correct types of vehicles, will achieve a sustained retirement through at least age 90,” Robinson said. At first, your withdrawal rate will be higher than average, which will obviously draw down your assets faster, but when Social Security kicks in, that rate will taper. For example, you have a substantial amount of money in your savings account.
The e-signature company thrived during the pandemic, but it missed signs of a slowdown as the pandemic faded and absorbed the biggest blow in its history. Two big stock buys triggered a rebound.
Nvidia and AMD have been best-of-breed growth stocks, as the stocks hit record highs. Here’s how to trade them now.
From January to November, 2.5 million electric vehicles (EVs) were sold in China, including plug-in hybrids. In the first half of this year, China accounted for roughly 42% of global EV sales. Global EV sales for 2021 are estimated to be around 6 million units, which means China will likely maintain its lead in EV sales for the year. Nearly 25% of Tesla’s (NASDAQ: TSLA) revenue for the first nine months of 2021 came from China.
It’s never fun when our stocks take a price hit, but we should be excited about the long-term opportunities that market corrections give us. Right now, there are several high-quality growth stocks that are 40%, 60%, or even 70% less expensive than earlier this year. Affirm Holdings (NASDAQ: AFRM) is poised to be at the center of this growth, thanks to its various partnerships with key U.S. retailers like Amazon, Shopify, Walmart, and Target. Its fiscal 2022 first-quarter earnings showcased an 84% year-over-year increase in gross merchandise volume, the total value of transactions on Affirm’s platform, which drove 55% revenue growth over 2021 Q1.
EV stocks have multiplied in Tesla’s wake and as electric cars look to go mainstream. Here are the top-rated electric vehicle makers.
The price of Bitcoin has tumbled over the past month. A number of Bitcoin stocks — or companies that have business tied to the cryptocurrency — have followed suit. Given the on-a-whim price swings in the crypto world, finding the best stocks out of that bunch can be difficult. For now, based solely on IBD’s chart analysis, the best crypto…
DEEP DIVE This is the time of the year when Wall Street prognosticators do their best to entertain investors with predictions. But after two excellent years for U.S. stocks, maybe it’s time to position yourself to enjoy high and well-supported dividends if the market turns sour in 2022.
Ford and Google stocks are arguably actionable now, leading several top stocks just above or below buy points amid uncertain market conditions.
With the third-quarter round of 13F filings behind us, it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the fourth quarter of 2021. One of these stocks was C3.ai, Inc. (NYSE: AI). Is AI a good stock […]
Apple’s (NASDAQ: AAPL) stock hit an all-time high on Dec. 9 after two influential analysts made bullish predictions about the tech giant’s future. Wedbush analyst Daniel Ives declared that global demand for the iPhone 13 was still outstripping its supply by about 10 million units, that its holiday sales would be strong, and that Apple’s upcoming launch of an augmented reality (AR) headset would significantly boost its sales and profits next year. Morgan Stanley’s Katy Huberty claimed Apple’s price didn’t reflect its upcoming AR, VR, and vehicle-related products yet, and that it would benefit from a “flight to quality” from other stocks. Both analysts have set a price target of $200 on Apple’s stock — roughly 14% above its current price.